PGEN:NASDAQ
Precigen Inc
7,36 US$
arrow_downward
-1,67%(-0,12) 1K
7,30 US$
arrow_downward
-0,75% (-0,055)bedtimeYopilgandan keyin
Savdolar yopilgan: 14-okt, 16:00:00 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoPGEN tikeri uchun statistika yaratilmoqda...
Ochish
7,48 US$
Yuqori
7,70 US$
Past
7,33 US$
Bozor kapitali
2,63 mlrd
Oʻrtacha hajm
4,68 mln
Hajmi
4,20 mln
52 haftalik eng yuqori
8,98 US$
52 haftalik eng past
3,04 US$
Aksiya boʻyicha daromad
-1,10 US$
Beta
0,92
Muomaladagi aksiyalar
358,04 mln
Xodimlar soni
160
Ochish
7,48 US$
Yuqori
7,70 US$
Past
7,33 US$
Bozor kapitali
2,63 mlrd
Oʻrtacha hajm
4,68 mln
Hajmi
4,20 mln
52 haftalik eng yuqori
8,98 US$
52 haftalik eng past
3,04 US$
Aksiya boʻyicha daromad
-1,10 US$
Beta
0,92
Muomaladagi aksiyalar
358,04 mln
Xodimlar soni
160
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Yahoo Finance
·
2 kun oldin
Precigen (PGEN): Commercial Launch Success Validates Early Capital Raise Thesis
Profil
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
Precigen Inc haqida